Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
158,835,667
-
Total 13F shares
-
90,107,125
-
Share change
-
+32,580
-
Total reported value
-
$1,370,540,354
-
Put/Call ratio
-
66%
-
Price per share
-
$15.21
-
Number of holders
-
234
-
Value change
-
-$16,725,794
-
Number of buys
-
115
-
Number of sells
-
106
Institutional Holders of TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) as of Q1 2024
As of 31 Mar 2024,
TG THERAPEUTICS, INC. - COMMON STOCK (TGTX) was held by
234 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
90,107,125 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, PICTET ASSET MANAGEMENT Holding SA, Soleus Capital Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, GEODE CAPITAL MANAGEMENT, LLC, Opaleye Management Inc., and BANK OF AMERICA CORP /DE/.
This page lists
234
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.